Come up with a name for your new list and we'll add to it:
Hingez Therapeutics raised a round of funding on September 18, 2018. Investors include
National Institutes of Health.
Hingez Therapeutics is using molecular simulations to discover an orally deliverable small molecule to disrupt disease protein-protein interactions; this has the potential to be developed as a new dru…